APP and Alzheimer disease: This research has significant novelties: first, evaluate whether treatment with pre- and probiotics could modify Abeta plaques and neurodegeneration in hippocampal CA1 and CA3 areas of APP/PS1 mice; second, prebiotics and probiotics are devoid of side effects and maintaining or recovering gut-MB composition, could represent a nutraceutical strategy to prevent or reduce AD.